Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BFPET for Myocardial Perfusion Imaging in CAD
NCT02252783Phase 2Unknown
- Sponsor
- FluoroPharma Medical
- Start
- Oct 2018
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BFPET in coronary artery disease (CAD), sponsored by FluoroPharma Medical. Status: unknown.
02
Drugs
BFPET
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02252783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02252783.